MoneyWorks4Me

Sudeep Pharma - Quaterly Results

05 Aug 2026 Evaluate
The sales surged to Rs. 1056.83 millions, up 31.82% for the June 2026 quarter as against Rs. 801.74 millions during the corresponding quarter previous year.Good  Net Profit growth of 34.22% reported above the corresponding previous quarter figure of Rs. 252.05 millions to Rs. 338.30 millioins.Operating profit surged to 489.95 millions from the corresponding previous quarter of 370.12 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 1056.83 801.74 31.82 1056.83 801.74 31.82 3385.05 3567.32 -5.11
Other Income 98.00 66.20 48.04 98.00 66.20 48.04 385.04 83.76 359.69
PBIDT 489.95 370.12 32.38 489.95 370.12 32.38 1582.72 1403.33 12.78
Interest 17.60 14.37 22.48 17.60 14.37 22.48 60.66 48.10 26.11
PBDT 472.35 355.75 32.78 472.35 355.75 32.78 1522.06 1355.23 12.31
Depreciation 18.26 17.48 4.46 18.26 17.48 4.46 71.10 61.17 16.23
PBT 454.09 338.27 34.24 454.09 338.27 34.24 1450.96 1294.06 12.12
TAX 115.79 86.22 34.30 115.79 86.22 34.30 375.16 336.59 11.46
Deferred Tax 17.23 4.25 305.41 17.23 4.25 305.41 31.93 5.26 507.03
PAT 338.30 252.05 34.22 338.30 252.05 34.22 1075.80 957.47 12.36
Equity 112.95 97.23 16.17 112.95 97.23 16.17 112.95 97.23 16.17
PBIDTM(%) 46.36 46.16 0.42 46.36 46.16 0.42 46.76 39.34 18.86

Sudeep Pharma Share Price

958.05 -15.70 (-1.61%)
07-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.00
Dr. Reddys Labs. 1172.00
Cipla 1472.00
Lupin 2360.00
Zydus Lifesciences 1115.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: